# A Clinical Study of YL205 in Patients With Advanced Solid Tumors

> **NCT06459973** · PHASE1,PHASE2 · RECRUITING · sponsor: **MediLink Therapeutics (Suzhou) Co., Ltd.** · enrollment: 252 (estimated)

## Conditions studied

- Advanced Solid Tumors

## Interventions

- **DRUG:** intravenous (IV) infusion

## Key facts

- **NCT ID:** NCT06459973
- **Lead sponsor:** MediLink Therapeutics (Suzhou) Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-06-04
- **Primary completion:** 2027-07-31
- **Final completion:** 2030-07-31
- **Target enrollment:** 252 (ESTIMATED)
- **Last updated:** 2025-12-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06459973

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06459973, "A Clinical Study of YL205 in Patients With Advanced Solid Tumors". Retrieved via AI Analytics 2026-09-15 from https://api.ai-analytics.org/clinical/NCT06459973. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*